This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...
A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Chinese scientists have genetically tweaked a fungus to make protein-rich “meat”, which they say can be a low-cost, ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results